Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity

被引:22
作者
Popiel, HA
Nagai, Y
Onodera, O
Inui, T
Fujikake, N
Urade, Y
Strittmatter, WJ
Burke, JR
Ichikawa, A
Toda, T
机构
[1] Osaka Univ, Grad Sch Med, Dept Post Genom & Dis, Div Funct Genom, Suita, Osaka, Japan
[2] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Physiol Chem, Kyoto, Japan
[3] Niigata Univ, Inst Brain Res, Dept Mol Neurosci, Niigata, Japan
[4] Tsu City Coll, Dept Food & Nutr, Tsu, Mie, Japan
[5] Osaka Biosci Inst, Dept Mol Behav Biol, Suita, Osaka, Japan
[6] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[7] Duke Univ, Med Ctr, Deane Lab, Durham, NC 27710 USA
[8] Mukogawa Womens Univ, Dept Pharmaceut Sci, Nishinomiya, Hyogo, Japan
关键词
aggregation; Huntington's disease; neurodegeneration; polyglutamine; proline mutagenesis; protein conformation;
D O I
10.1016/j.bbrc.2004.03.161
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The polyglutamine (polyQ) diseases are a class of inherited neurodegenerative diseases including Huntington's disease, caused by the expansion of a polyQ stretch within each disease protein. This expansion is thought to cause a conformational change in the protein leading to aggregation of the protein, resulting in cytotoxicity. To analyze whether disrupting the toxic conformation of the polyQ protein can alter its aggregation propensity and cytotoxicity, we examined the effect of interruption of the expanded polyQ stretch by proline insertion, since prolines cause great alterations in protein conformation. Here, we show that insertion of prolines into the expanded polyQ stretch indeed disrupts its ordered secondary structure, leading to suppression of polyQ protein aggregation both in vitro and in cell culture, and reduction of cytotoxicity in correlation with the number of proline interruptions. Furthermore, we found that a short polyQ stretch with a proline interruption is able to inhibit aggregation of the expanded polyQ protein in trans. These results show that a gain in toxic conformation of the expanded polyQ protein is essential for aggregation and cytotoxicity, providing insight into establishing therapies against the polyQ diseases. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:1200 / 1206
页数:7
相关论文
共 29 条
[1]   Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases [J].
Bucciantini, M ;
Giannoni, E ;
Chiti, F ;
Baroni, F ;
Formigli, L ;
Zurdo, JS ;
Taddei, N ;
Ramponi, G ;
Dobson, CM ;
Stefani, M .
NATURE, 2002, 416 (6880) :507-511
[2]   Phenotypic effects of expanded ataxin-1 polyglutamines with interruptions in vitro [J].
Calabresi, V ;
Guida, S ;
Servadio, A ;
Jodice, C .
BRAIN RESEARCH BULLETIN, 2001, 56 (3-4) :337-342
[3]   Protofibrils, pores, fibrils, and neurodegeneration: Separating the responsible protein aggregates from the innocent bystanders [J].
Caughey, B ;
Lansbury, PT .
ANNUAL REVIEW OF NEUROSCIENCE, 2003, 26 :267-298
[4]  
Chai YH, 1999, J NEUROSCI, V19, P10338
[5]   Amyloid-like features of polyglutamine aggregates and their assembly kinetics [J].
Chen, SM ;
Berthelier, V ;
Hamilton, JB ;
O'Nuallain, B ;
Wetzel, R .
BIOCHEMISTRY, 2002, 41 (23) :7391-7399
[6]   Amyloid fibril formation in the context of full-length protein -: Effects of proline mutations on the amyloid fibril formation of β2-microglobulin [J].
Chiba, T ;
Hagihara, Y ;
Higurashi, T ;
Hasegawa, K ;
Naiki, H ;
Goto, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (47) :47016-47024
[7]   CAG repeat instability, cryptic sequence variation and pathogeneticity: evidence from different loci [J].
Frontali, M ;
Novelletto, A ;
Annesi, G ;
Jodice, C .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES, 1999, 354 (1386) :1089-1094
[8]   Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease [J].
Gusella, JF ;
MacDonald, ME .
NATURE REVIEWS NEUROSCIENCE, 2000, 1 (02) :109-115
[9]   Expansion explosion: new clues to the pathogenesis of repeat expansion neurodegenerative diseases [J].
Margolis, RL ;
Ross, CA .
TRENDS IN MOLECULAR MEDICINE, 2001, 7 (11) :479-482
[10]   Prevention of polyglutamine oligomerization and neurodegeneration by the peptide inhibitor QBP1 in Drosophila [J].
Nagai, Y ;
Fujikake, N ;
Ohno, K ;
Higashiyama, H ;
Popiel, HA ;
Rahadian, J ;
Yamaguchi, M ;
Strittmatter, WJ ;
Burke, JR ;
Toda, T .
HUMAN MOLECULAR GENETICS, 2003, 12 (11) :1253-1259